KRAZATI Logo (EUIPO, 02/08/2023)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark KRAZATI was filed as Figurative mark on 02/08/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/31/2023.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Lines or bands forming an angle #Letters or numerals forming a triangle (surface or periphery)
| Trademark form | Figurative mark |
| File reference | 018833418 |
| Application date | February 8, 2023 |
| Publication date | February 21, 2023 |
| Entry date | May 31, 2023 |
| Expiration date | February 8, 2033 |
Trademark owner
3545 Cray Court
92121 San Diego
US
92121 San Diego
US
Trademark representatives
Avda. Diagonal, 640, 6ª planta
08017 Barcelona
ES
goods and services
5
Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
42
Research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
ID: 11018833418